Question:
For this year, how will DME infusion drugs be paid by Medicare?
Answer:
For claims with a date of service on or after January 1, 2017, most of the payment for infusion drugs furnished through a covered item of durable medical equipment (DME) will be based on the average sales price (ASP) of the drugs. Medicare Administrative Contractors (MACs) will determine payment for DME infusion drugs that do not appear on the ASP drug-pricing files.